Companies’ environmental, social and governance (“ESG”) narratives are increasingly important. The highly regulated life sciences and healthcare (“LSHC”) sector is often criticised for its high water and carbon usage, and its waste creation. LSHC companies are likely to come under increased scrutiny in this regard.
If ESG issues and risks are not managed effectively, the potential arises for regulatory enforcement, civil litigation, criminal sanctions, and reputational harm. LSHC companies and their legal advisers should be alive to these issues, and they should be incorporated into risk management strategies and monitored accordingly.
This article, part of our Healthy Horizons guide to doing business responsibly in Life Sciences & Healthcare outlines some key litigation risk areas and how they can be managed and incorporated into a company’s risk management strategy.
Click here to read more.
Sign up for our forthcoming webinar on 9 November to hear more about this subject - Healthy Horizons Webinar Series (cms.law)
